Feider Stephen 的 Form 4/A 修正申報
修正Beta Bionics, Inc.（BBNX），2026/7/2 申報
- 申報編號
- 0002048588-26-000010
- 申報時間
- 2026/7/2 18:44 ET
- 交易日
- 2026/6/26-6/29
- 申報延遲
- 6 天
- 10b5-1 計畫
- 有勾選
- 原始申報日
- 2026/6/30
這份申報列了 4 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $17.0 萬。交易後 6 天申報。
這份修正申報取代了 0002048588-26-000009（2026/6/30 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Feider StephenCIK 0002048588 | 高階主管（財務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/6/26 | Common Stock | M行使選擇權處分 | −5,104 | $0.00 | $0 | 44,591 | 直接 | |
| 2026/6/29 | Common Stock | M行使選擇權處分 | −4,896 | $0.00 | $0 | 39,695 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.
- F2
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
- F3
The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.